MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer.
MSN/STAT3 通过 IL-6/LPAR1 配体受体复合物驱动三阴性乳腺癌的干性和化疗耐药性
期刊:Breast Cancer Research
影响因子:5.6
doi:10.1186/s13058-025-02072-z
Lee Cheng Hyun, Park Soo Young, Lee Jae Seok, Kim Da Sol, Kim Ha Yeon, Song Min Ji, Im Seock-Ah, Lee Kyung-Hun, Lee Dae-Won, Nikas Ilias P, Koh Ji Won, Yang So Hyeon, Lee Hyebin, Ryu Han Suk
